February 20, 2010 - Volume 24 - Issue 4
pp: 479-620



Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies

Vingerhoets, Johan; Tambuyzer, Lotke; Azijn, Hilde; More

AIDS . 24(4):503-514, February 20, 2010.

Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case–control study

Judd, Ali; Boyd, Katherine L; Stöhr, Wolfgang; More

AIDS . 24(4):525-534, February 20, 2010.

Anal cancers among HIV-infected persons: HAART is not slowing rising incidence

Crum-Cianflone, Nancy F; Hullsiek, Katherine Huppler; Marconi, Vincent C; More

AIDS . 24(4):535-543, February 20, 2010.

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals

Landrum, Michael L; Hullsiek, Katherine Huppler; Ganesan, Anuradha; More

AIDS . 24(4):545-555, February 20, 2010.

Concise Communication


Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration

Hudelson, Sarah E; McConnell, Michelle S; Bagenda, Danstan; More

AIDS . 24(4):557-561, February 20, 2010.


Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

Boulle, Andrew; Van Cutsem, Gilles; Hilderbrand, Katherine; More

AIDS . 24(4):563-572, February 20, 2010.

Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection

Morrison, Charles S; Demers, Korey; Kwok, Cynthia; More

AIDS . 24(4):573-582, February 20, 2010.

A genome-wide association study of carotid atherosclerosis in HIV-infected men

Shrestha, Sadeep; Irvin, Marguerite R; Taylor, Kent D; More

AIDS . 24(4):583-592, February 20, 2010.

Concise Communication



Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy

Guihot, Amélie; Tubiana, Roland; Breton, Guillaume; More

AIDS . 24(4):614-617, February 20, 2010.